National Institutes of Health: all 11,571 studies

Page 20 of 116. Open to participants first (946), then studies with results posted, then the rest; newest registration first within each.

• The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung DiseaseCompletedNCT02019641Not applicableResults posted
• Study of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCGCompletedNCT02015104Phase 2Results posted
• Phase II Trial of Vandetanib in Children and Adults With Wild-Type Gastrointestinal Stromal TumorsCompletedNCT02015065Phase 2Results posted
• Pilot Trial of Botulinum Toxin and Occupational Therapy for Writer's CrampCompletedNCT02015039Phase 1/2Results posted
• Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing SurgeryCompletedNCT02007200Phase 2Results posted
• Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic LeukemiaActive, not recruitingNCT02003222Phase 3Results posted
• Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast CancerCompletedNCT02003209Phase 3Results posted
• Study of Adrenalectomy Versus Observation for Subclinical HypercortisolismTerminatedNCT02001051Phase 2Results posted
• Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis VulgarisCompletedNCT01999868Phase 2Results posted
• Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic MelanomaCompletedNCT01993719Phase 2Results posted
• Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT01989598Phase 2Results posted
• Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By SurgeryCompletedNCT01989572Phase 3Results posted
• Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA MutationsCompletedNCT01989546Phase 1/2Results posted
• Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive FibromatosisCompletedNCT01981551Phase 2Results posted
• Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell LymphomaCompletedNCT01979536Phase 2Results posted
• Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal MelanomaActive, not recruitingNCT01979523Phase 2Results posted
• A Randomized, Controlled, Double-Masked, Clinical Trial of Autologous Serum Eye Drops for Severe Ocular Chronic Graft-versus-Host Disease (GVHD) in Hematopoietic Stem Cell Transplant (HSCT) PatientsTerminatedNCT01972438Phase 2Results posted
• Evaluation of Anti-Hemagglutinin (Anti-HA) Antibodies as Protection From the Flu in Healthy PeopleCompletedNCT01971255Phase 1/2Results posted
• T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing CancerCompletedNCT01967823Phase 2Results posted
• Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/ParagangliomaCompletedNCT01967576Phase 2Results posted
• Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine TumorsCompletedNCT01967537Phase 2Results posted
• Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Metastatic Triple-Negative Breast CancerCompletedNCT01964924Phase 2Results posted
• Evaluation of Oral Activated Charcoal on Antimalarial Drug's Ability to Kill Parasites in Malian Children With MalariaCompletedNCT01955382Phase 2Results posted
• Trichuris Suis Ova Treatment in Left-sided Ulcerative ColitisTerminatedNCT01953354Phase 2Results posted
• Study of Human Non-Shivering Thermogenesis and Basal Metabolic RateCompletedNCT01950520Phase 2Results posted
• Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by SurgeryCompletedNCT01950390Phase 2Results posted
• Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV MedicationsCompletedNCT01949116Phase 2Results posted
• Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)TerminatedNCT01946880Phase 2Results posted
• Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung CancerTerminatedNCT01935947Phase 2Results posted
• Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial CancerCompletedNCT01935934Phase 2Results posted
• Defining Immune Tolerance in ANCA-associated Vasculitis (AAV)TerminatedNCT01934504Results posted
• Evaluating the Safety and Efficacy of Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral LoadCompletedNCT01933594Phase 1/2Results posted
• Medical Arm of the Interagency Registry for Mechanically Assisted Circulatory SupportCompletedNCT01932294Results posted
• Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior BevacizumabCompletedNCT01931098Phase 2Results posted
• Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine GliomasCompletedNCT01922076Phase 1Results posted
• Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03)CompletedNCT01910519Phase 2Results posted
• Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Acute Myeloid LeukemiaTerminatedNCT01907815Phase 2Results posted
• Peanut Epicutaneous Phase II Immunotherapy Clinical TrialCompletedNCT01904604Phase 2Results posted
• Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV CancerCompletedNCT01902173Phase 1/2Results posted
• Extended Dosing With Eltrombopag for Severe Aplastic AnemiaCompletedNCT01891994Phase 2Results posted
• New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis CCompletedNCT01888900Phase 2Results posted
• A Trial of the Drug Donepezil for Sleep Enhancement and Behavioral Change in Children With AutismTerminatedNCT01887132Phase 2Results posted
• Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic LeukemiaActive, not recruitingNCT01886872Phase 3Results posted
• HALT Progression of Polycystic Kidney Disease Study BCompletedNCT01885559Phase 3Results posted
• Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIVCompletedNCT01878799Phase 2Results posted
• Genetic Effects on Dopamine Response to an OpiateCompletedNCT01878006Phase 2Results posted
• Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate CancerCompletedNCT01875250Phase 2Results posted
• Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid LeukemiaCompletedNCT01870596Phase 2Results posted
• Peanut Oral Immunotherapy in ChildrenCompletedNCT01867671Phase 2Results posted
• Gadoxetate Enhanced Imaging Study to Detect Prostate CancerCompletedNCT01867424Phase 2Results posted
• Enzalutamide With or Without Vaccine Therapy for Advanced Prostate CancerCompletedNCT01867333Phase 2Results posted
• Preventing Stem Cell Transplant Complications With a Blood Separator MachineCompletedNCT01866839Phase 1/2Results posted
• Rifaximin for Chronic Immune Activation in People With HIVCompletedNCT01866826Phase 1/2Results posted
• Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung CancerCompletedNCT01866410Phase 2Results posted
• Predicting Adherence to a Heart-Healthy Diet in Lean and Obese IndividualsCompletedNCT01862796Not applicableResults posted
• Effects of Roflumilast on Insulin and Blood Sugar Levels in Prediabetic Overweight and Obese IndividualsCompletedNCT01862029Phase 1/2Results posted
• Tivantinib in Treating Patients With Previously Treated Malignant MesotheliomaTerminatedNCT01861301Phase 2Results posted
• Therapeutic Vaccine for HIVCompletedNCT01859325Phase 1Results posted
• Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal HyperplasiaCompletedNCT01859312Phase 2Results posted
• Folic Acid and Zinc Supplementation Trial (FAZST)CompletedNCT01857310Not applicableResults posted
• Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal CancerTerminatedNCT01856322Phase 2Results posted
• Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive RegimenTerminatedNCT01856257Phase 2Results posted
• Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell LymphomaActive, not recruitingNCT01856192Phase 2Results posted
• Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary AtresiaCompletedNCT01854827Phase 1/2Results posted
• Idebenone for Primary Progressive Multiple SclerosisCompletedNCT01854359Phase 1/2Results posted
• Tremelimumab With Chemoembolization or Ablation for Liver CancerCompletedNCT01853618Phase 1/2Results posted
• TRC102 and Temozolomide for Relapsed Solid Tumors and LymphomasCompletedNCT01851369Phase 1/2Results posted
• Ibrutinib in Treating Patients With Relapsed or Refractory Follicular LymphomaActive, not recruitingNCT01849263Phase 2Results posted
• Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer SurvivorsCompletedNCT01849250Phase 2Results posted
• Laboratory Study of Cannabidiol on the Effects of Smoked MarijuanaCompletedNCT01844687Phase 2Results posted
• Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid TumorsActive, not recruitingNCT01841736Phase 2Results posted
• Nitisinone for Type 1B Oculocutaneous AlbinismCompletedNCT01838655Phase 1/2Results posted
• Ponatinib for Advanced Medullary Thyroid CancerTerminatedNCT01838642Phase 2Results posted
• Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney CancerCompletedNCT01835158Phase 2Results posted
• Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by SurgeryCompletedNCT01835145Phase 2Results posted
• Gevokizumab for Active ScleritisCompletedNCT01835132Phase 1/2Results posted
• Surgery and Heated Chemotherapy for Adrenocortical CarcinomaCompletedNCT01833832Phase 2Results posted
• Evaluating the Safety and Pharmacokinetics of Raltegravir in InfantsCompletedNCT01828073Results posted
• MPACT Study to Compare Effects of Targeted Drugs on Tumor Gene VariationsCompletedNCT01827384Phase 2Results posted
• Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®CompletedNCT01827371Phase 2Results posted
• Safety and Efficacy of Mupirocin in Eradicating Colonization With S. Aureus in Critically Ill InfantsCompletedNCT01827358Phase 2Results posted
• Three Strategies for Implementing Motivational Interviewing on Medical Inpatient UnitsCompletedNCT01825057Not applicableResults posted
• Cabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency VirusCompletedNCT01822522Phase 1Results posted
• Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung CancerTerminatedNCT01822496Phase 2Results posted
• Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular MelanomaTerminatedNCT01814046Phase 2Results posted
• Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid CancerCompletedNCT01811212Phase 2Results posted
• Combination Therapy for Chronic Hepatitis C InfectionCompletedNCT01805882Phase 2Results posted
• Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid LeukemiaCompletedNCT01802333Phase 3Results posted
• Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by SurgeryCompletedNCT01802320Phase 2Results posted
• Rilonacept for Deficiency of the Interleukin-1 Receptor Antagonist (DIRA)CompletedNCT01801449Phase 2Results posted
• Anakinra for Inflammatory Pustular Skin DiseasesCompletedNCT01794117Phase 2Results posted
• Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin ECompletedNCT01792115Phase 2Results posted
• Optimization of NULOJIX® Usage Towards Minimizing CNI Exposure in Simultaneous Pancreas and Kidney TransplantationTerminatedNCT01790594Phase 2Results posted
• Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological MalignanciesCompletedNCT01789255Phase 2Results posted
• Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG) Follow-up Observational Study II ProtocolCompletedNCT01783990Results posted
• Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at Risk of Acquiring HIV-1 InfectionCompletedNCT01780831Phase 1Results posted
• Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin LymphomaCompletedNCT01780662Phase 1/2Results posted
• Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy DrinkersCompletedNCT01779024Phase 2Results posted
• Short-term Effects of Leptin in People With LipodystrophyCompletedNCT01778556Phase 2Results posted
• TRC105 for Recurrent GlioblastomaTerminatedNCT01778530Phase 2Results posted

← National Institutes of Health overview and focus areas